Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies
Clinical trial NCT06607120 · RECRUITING
Trial details
- NCT number
- NCT06607120
- Sponsor
- Zhongda Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-01-31
- Enrollment
- 950
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.